Once the technology and knowledge around biomarkers and profiling that is molecular to expand, oncology providers are challenged with effortlessly applying molecular screening to their each and every day training. To increase understanding about biomarker screening, increase usage of client and provider education materials, and establish a good system of advocacy and expert lovers to greatly help facilitate the integration of accuracy medicine into training, the Association of Community Cancer Centers (ACCC) has launched the BiomarkerLIVE training system.
Findings from ACCC’s shows through the 2018
Trending Now in Cancer Care Survey suggested that functional dilemmas such as for example insurance plan, reimbursement, and inadequate protocols had been typical barriers to biomarker evaluation. Directed by a professional Advisory Committee and partner, Cancer Support Community, ACCC leveraged these findings to provide stage hands down the BiomarkerLIVE system: growth of a lexicon of comprehensive terminology to enable the care group; establishment of a resource bank of nationwide available materials highly relevant to cancer tumors biomarkers and biomarker testing—filterable by cancer tumors kind, part of application, and/or main market; and launch of a how-to webinar that further explores exactly exactly just how cancer tumors programs may use these tools to make usage of effective biomarker testing protocols for clients.
Cancer care is in the midst of a massive paradigm change. We’re in a landscape that is rapidly expanding of cancers are identified, treated, and also prevented. I am therefore very happy to engage in this essential academic endeavor led by ACCC. ”
Patricia Buddy, PhD, APRN-CNS, AOCNS, AGN-BC, Associate Professor and Program Director, Marcella Niehoff Class of Nursing, Loyola University Chicago